{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T11:47:39Z","timestamp":1793274459142,"version":"4.5.0"},"reference-count":83,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T00:00:00Z","timestamp":1604016000000},"content-version":"vor","delay-in-days":1398,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2017]]},"DOI":"10.1136\/esmoopen-2017-000250","type":"journal-article","created":{"date-parts":[[2017,12,18]],"date-time":"2017-12-18T20:40:29Z","timestamp":1513629629000},"page":"e000250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":185,"title":["Biology of premature ageing in survivors of cancer"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0943-9250","authenticated-orcid":false,"given":"Margaret C.","family":"Cupit-Link","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L.","family":"Kirkland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten K.","family":"Ness","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory T.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamar","family":"Tchkonia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan K.","family":"LeBrasseur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saro H.","family":"Armenian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn J.","family":"Ruddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrukh K.","family":"Hashmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/esmoopen-2017-000250_bb0010","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1136\/esmoopen-2017-000250_bb0015","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1056\/NEJMsa060185","article-title":"Chronic health conditions in adult survivors of childhood cancer;","volume":"355","author":"Oeffinger","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1136\/esmoopen-2017-000250_bb0020","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1200\/JCO.2008.21.1425","article-title":"Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study","volume":"27","author":"Armstrong","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1136\/esmoopen-2017-000250_bb0025","doi-asserted-by":"crossref","first-page":"1277-1286","DOI":"10.1001\/jamaoncol.2016.0855","article-title":"Physiologic frailty in nonelderly hematopoietic cell transplantation patients: results from the bone marrow transplant survivor study","volume":"2","author":"Arora","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1136\/esmoopen-2017-000250_bb0030","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1056\/NEJMoa1510795","article-title":"Reduction in late mortality among 5-year survivors of childhood cancer","volume":"374","author":"Armstrong","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1136\/esmoopen-2017-000250_bb0035","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1158\/1055-9965.EPI-14-1418","article-title":"Survivors of childhood cancer in the United States: prevalence and burden of morbidity","volume":"24","author":"Phillips","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1136\/esmoopen-2017-000250_bb0040","unstructured":"From cancer patient to cancer survivor: lost in transition. In: MGSHewitt, EStovall, eds. Washington, DC: National Academies Press."},{"key":"10.1136\/esmoopen-2017-000250_bb0045","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/bmt.2015.228","article-title":"Childhood to adult transition and long-term follow-up after blood and marrow transplantation","volume":"51","author":"Cupit","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1136\/esmoopen-2017-000250_bb0050","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.bbmt.2014.06.035","article-title":"Lost in transition: the essential need for long-term follow-up clinic for blood and marrow transplantation survivors","volume":"21","author":"Hashmi","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1136\/esmoopen-2017-000250_bb0055","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","article-title":"The hallmarks of aging","volume":"153","author":"L\u00f3pez-Ot\u00edn","year":"2013","journal-title":"Cell"},{"key":"10.1136\/esmoopen-2017-000250_bb0060","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1200\/JCO.2013.51.1055","article-title":"Aging and risk of severe, disabling, life-threatening, and fatal events in the childhood cancer survivor study","volume":"32","author":"Armstrong","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1136\/esmoopen-2017-000250_bb0065","doi-asserted-by":"crossref","first-page":"6596","DOI":"10.1200\/JCO.2005.12.674","article-title":"Late effects of hematopoietic cell transplantation among 10-year adult survivors compared with case-matched controls","volume":"23","author":"Syrjala","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1136\/esmoopen-2017-000250_bb0070","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/S1470-2045(16)30215-7","article-title":"Cumulative burden of cardiovascular morbidity in paediatric, adolescent, and young adult survivors of Hodgkin\u2019s lymphoma: an analysis from the St Jude Lifetime Cohort Study","volume":"17","author":"Bhakta","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1136\/esmoopen-2017-000250_bb0075","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/jnci\/djq238","article-title":"Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study","volume":"102","author":"Friedman","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1136\/esmoopen-2017-000250_bb0080","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1001\/jama.2011.747","article-title":"Long-term risks of subsequent primary neoplasms among survivors of childhood cancer","volume":"305","author":"Reulen","year":"2011","journal-title":"JAMA"},{"key":"10.1136\/esmoopen-2017-000250_bb0085","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/jnci\/djp104","article-title":"Lifelong cancer incidence in 47,697 patients treated for childhood cancer in the Nordic countries","volume":"101","author":"Olsen","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1136\/esmoopen-2017-000250_bb0090","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1038\/bcj.2011.14","article-title":"Long-term complications and side effects after allogeneic hematopoietic stem cell transplantation: an update","volume":"1","author":"Mohty","year":"2011","journal-title":"Blood Cancer J"},{"key":"10.1136\/esmoopen-2017-000250_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2318-2-1","article-title":"Frailty, fitness and late-life mortality in relation to chronological and biological age","volume":"2","author":"Mitnitski","year":"2002","journal-title":"BMC Geriatr"},{"key":"10.1136\/esmoopen-2017-000250_bb0100","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/35041682","article-title":"Why do we age?","volume":"408","author":"Kirkwood","year":"2000","journal-title":"Nature"},{"key":"10.1136\/esmoopen-2017-000250_bb0105","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/j.1532-5415.2006.00745.x","article-title":"Research agenda for frailty in older adults: toward a better understanding of physiology and etiology: summary from the American Geriatrics Society\/National Institute on Aging Research Conference on Frailty in Older Adults","volume":"54","author":"Walston","year":"2006","journal-title":"J Am Geriatr Soc"},{"key":"10.1136\/esmoopen-2017-000250_bb0110","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.arr.2015.12.003","article-title":"Frailty assessment instruments: systematic characterization of the uses and contexts of highly-cited instruments","volume":"26","author":"Buta","year":"2016","journal-title":"Ageing Res Rev"},{"key":"10.1136\/esmoopen-2017-000250_bb0115","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1111\/j.1532-5415.2011.03597.x","article-title":"The identification of frailty: a systematic literature review","volume":"59","author":"Sternberg","year":"2011","journal-title":"J Am Geriatr Soc"},{"key":"10.1136\/esmoopen-2017-000250_bb0120","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1111\/j.1532-5415.2012.04054.x","article-title":"Prevalence of frailty in community-dwelling older persons: a systematic review","volume":"60","author":"Collard","year":"2012","journal-title":"J Am Geriatr Soc"},{"key":"10.1136\/esmoopen-2017-000250_bb0125","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1182\/blood.V126.23.739.739","article-title":"Physiologic frailty among hematopoietic cell transplantation (HCT) survivors suggests accelerated aging and is a predictor for premature mortality: a report from the Bone Marrow Transplant Survivor Study (BMTSS)","volume":"126","author":"Arora","year":"2015","journal-title":"Blood"},{"key":"10.1136\/esmoopen-2017-000250_bb0130","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.bbmt.2013.04.002","article-title":"Burden of morbidity in 10+ year survivors of hematopoietic cell transplantation: report from the bone marrow transplantation survivor study","volume":"19","author":"Sun","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1136\/esmoopen-2017-000250_bb0135","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1056\/NEJM194806032382301","article-title":"Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid","volume":"238","author":"Farber","year":"1948","journal-title":"N Engl J Med"},{"key":"10.1136\/esmoopen-2017-000250_bb0140","first-page":"225","article-title":"Cancer statistics, 2009","volume":"59","author":"Jemal","year":"2009","journal-title":"CA Cancer J Clin"},{"key":"10.1136\/esmoopen-2017-000250_bb0145","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/cncr.29170","article-title":"Conditional survival in pediatric malignancies: analysis of data from the childhood cancer survivor study and the surveillance, epidemiology, and end results program","volume":"121","author":"Mertens","year":"2015","journal-title":"Cancer"},{"key":"10.1136\/esmoopen-2017-000250_bb0150","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1001\/jama.290.12.1583","article-title":"Health status of adult long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study","volume":"290","author":"Hudson","year":"2003","journal-title":"JAMA"},{"key":"10.1136\/esmoopen-2017-000250_bb0155","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1200\/JCO.2014.57.4863","article-title":"Age-dependent changes in health status in the Childhood Cancer Survivor cohort","volume":"33","author":"Hudson","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1136\/esmoopen-2017-000250_bb0160","doi-asserted-by":"crossref","first-page":"4496","DOI":"10.1200\/JCO.2013.52.2268","article-title":"Physiologic frailty as a sign of accelerated aging among adult survivors of childhood cancer: a report from the St Jude Lifetime cohort study","volume":"31","author":"Ness","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1136\/esmoopen-2017-000250_bb0165","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/jnci\/djt089","article-title":"Evaluation of memory impairment in aging adult survivors of childhood acute lymphoblastic leukemia treated with cranial radiotherapy","volume":"105","author":"Armstrong","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1136\/esmoopen-2017-000250_bb0170","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1182\/blood-2011-01-331835","article-title":"Long-term health-related outcomes in survivors of childhood cancer treated with HSCT versus conventional therapy: a report from the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS)","volume":"118","author":"Armenian","year":"2011","journal-title":"Blood"},{"key":"10.1136\/esmoopen-2017-000250_bb0175","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1634\/theoncologist.1-5-293","article-title":"Dose intensity of chemotherapy for childhood cancers","volume":"1","author":"Smith","year":"1996","journal-title":"Oncologist"},{"key":"10.1136\/esmoopen-2017-000250_bb0180","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1182\/blood-2014-02-514778","article-title":"Conditioning regimens for hematopoietic cell transplantation: one size does not fit all","volume":"124","author":"Gyurkocza","year":"2014","journal-title":"Blood"},{"key":"10.1136\/esmoopen-2017-000250_bb0185","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.mehy.2006.01.045","article-title":"Possible acceleration of aging by adjuvant chemotherapy: a cause of early onset frailty?","volume":"67","author":"Maccormick","year":"2006","journal-title":"Med Hypotheses"},{"key":"10.1136\/esmoopen-2017-000250_bb0190","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1093\/annonc\/mdt551","article-title":"Muscle dysfunction in cancer patients","volume":"25","author":"Christensen","year":"2014","journal-title":"Ann Oncol"},{"issue":"Pt 1","key":"10.1136\/esmoopen-2017-000250_bb0195","first-page":"E627","article-title":"Prolonged bed rest decreases skeletal muscle and whole body protein synthesis","volume":"270","author":"Ferrando","year":"1996","journal-title":"Am J Physiol"},{"key":"10.1136\/esmoopen-2017-000250_bb0200","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.otc.2010.04.003","article-title":"A comprehensive review of the adverse effects of systemic corticosteroids","volume":"43","author":"Poetker","year":"2010","journal-title":"Otolaryngol Clin North Am"},{"key":"10.1136\/esmoopen-2017-000250_bb0205","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1172\/JCI64098","article-title":"Cellular senescence and the senescent secretory phenotype: therapeutic opportunities","volume":"123","author":"Tchkonia","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1136\/esmoopen-2017-000250_bb0210","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0165-1110(96)90006-8","article-title":"The roles of telomeres and telomerase in cell life span","volume":"366","author":"Counter","year":"1996","journal-title":"Mutat Res"},{"key":"10.1136\/esmoopen-2017-000250_bb0215","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/acel.12050","article-title":"Telomere length behaves as biomarker of somatic redundancy rather than biological age","volume":"12","author":"Boonekamp","year":"2013","journal-title":"Aging Cell"},{"key":"10.1136\/esmoopen-2017-000250_bb0220","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1158\/1055-9965.EPI-11-0005","article-title":"The association of telomere length and cancer: a meta-analysis","volume":"20","author":"Wentzensen","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1136\/esmoopen-2017-000250_bb0225","first-page":"559","article-title":"Loss of telomeric DNA during aging may predispose cells to cancer (review)","volume":"3","author":"Shay","year":"1993","journal-title":"Int J Oncol"},{"key":"10.1136\/esmoopen-2017-000250_bb0230","doi-asserted-by":"crossref","first-page":"9363","DOI":"10.1073\/pnas.92.20.9363","article-title":"A biomarker that identifies senescent human cells in culture and in aging skin in vivo","volume":"92","author":"Dimri","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1136\/esmoopen-2017-000250_bb0235","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.12997","article-title":"Targeting senescent cells enhances adipogenesis and metabolic function in old age","volume":"4","author":"Xu","year":"2015","journal-title":"Elife"},{"key":"10.1136\/esmoopen-2017-000250_bb0240","first-page":"518","article-title":"Structure and variability of human chromosome ends","volume":"10","author":"de Lange","year":"1990","journal-title":"Mol Cell Biol"},{"key":"10.1136\/esmoopen-2017-000250_bb0245","doi-asserted-by":"crossref","first-page":"E6301","DOI":"10.1073\/pnas.1515386112","article-title":"JAK inhibition alleviates the cellular senescence-associated secretory phenotype and frailty in old age","volume":"112","author":"Xu","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1136\/esmoopen-2017-000250_bb0250","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1126\/science.7605428","article-title":"Specific association of human telomerase activity with immortal cells and cancer","volume":"266","author":"Kim","year":"1994","journal-title":"Science"},{"key":"10.1136\/esmoopen-2017-000250_bb0255","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/13495","article-title":"Inhibition of telomerase limits the growth of human cancer cells","volume":"5","author":"Hahn","year":"1999","journal-title":"Nat Med"},{"key":"10.1136\/esmoopen-2017-000250_bb0260","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.mrfmmm.2011.07.006","article-title":"Is telomerase a viable target in cancer?","volume":"730","author":"Buseman","year":"2012","journal-title":"Mutat Res"},{"key":"10.1136\/esmoopen-2017-000250_bb0265","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/sj.leu.2402815","article-title":"Telomere dynamics in childhood leukemia and solid tumors: a follow-up study","volume":"17","author":"Franco","year":"2003","journal-title":"Leukemia"},{"key":"10.1136\/esmoopen-2017-000250_bb0270","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/sj.cr.7290110","article-title":"Effects of cisplatin on telomerase activity and telomere length in BEL-7404 human hepatoma cells","volume":"12","author":"Zhang","year":"2002","journal-title":"Cell Res"},{"key":"10.1136\/esmoopen-2017-000250_bb0275","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cell.2005.11.020","article-title":"Short telomeres, even in the presence of telomerase, limit tissue renewal capacity","volume":"123","author":"Hao","year":"2005","journal-title":"Cell"},{"key":"10.1136\/esmoopen-2017-000250_bb0280","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0047-6374(79)90082-4","article-title":"Proliferative capacity of erythropoietic stem cell lines and aging: an overview","volume":"9","author":"Harrison","year":"1979","journal-title":"Mech Ageing Dev"},{"key":"10.1136\/esmoopen-2017-000250_bb0285","series-title":"Bone marrow-derived progenitors","first-page":"67","article-title":"Bone marrow-derived cells: the influence of aging and cellular senescence","author":"Beaus\u00e9jour","year":"2007"},{"key":"10.1136\/esmoopen-2017-000250_bb0290","first-page":"18","article-title":"Nuclear factor-kappaB p65 mediates tumor necrosis factor alpha-induced nuclear translocation of telomerase reverse transcriptase protein","volume":"63","author":"Akiyama","year":"2003","journal-title":"Cancer Res"},{"key":"10.1136\/esmoopen-2017-000250_bb0295","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0140-6736(97)08256-1","article-title":"Accelerated telomere shortening in young recipients of allogeneic bone-marrow transplants","volume":"351","author":"Wynn","year":"1998","journal-title":"Lancet"},{"key":"10.1136\/esmoopen-2017-000250_bb0300","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1056\/NEJM197505222922107","article-title":"The clinical pharmacology of antineoplastic agents","volume":"292","author":"Chabner","year":"1975","journal-title":"N Engl J Med Overseas Ed"},{"key":"10.1136\/esmoopen-2017-000250_bb0305","first-page":"47","article-title":"Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure","volume":"19","author":"Levine","year":"1992","journal-title":"Semin Oncol"},{"key":"10.1136\/esmoopen-2017-000250_bb0310","doi-asserted-by":"crossref","first-page":"10604","DOI":"10.1073\/pnas.0500398102","article-title":"Epigenetic differences arise during the lifetime of monozygotic twins","volume":"102","author":"Fraga","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1136\/esmoopen-2017-000250_bb0315","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1196\/annals.1395.005","article-title":"Cross-talk between aging and cancer: the epigenetic language","volume":"1100","author":"Fraga","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1136\/esmoopen-2017-000250_bb0320","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.ijrobp.2010.09.048","article-title":"MicroRNA regulation of ionizing radiation-induced premature senescence","volume":"81","author":"Wang","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11-12","key":"10.1136\/esmoopen-2017-000250_bb0325","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.mad.2009.09.002","article-title":"Alterations in microRNA expression in stress-induced cellular senescence","volume":"130","author":"Li","year":"2009","journal-title":"Mech Ageing Dev"},{"key":"10.1136\/esmoopen-2017-000250_bb0330","first-page":"2705","article-title":"Tumor cell senescence in cancer treatment","volume":"63","author":"Roninson","year":"2003","journal-title":"Cancer Res"},{"key":"10.1136\/esmoopen-2017-000250_bb0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mrrev.2015.07.001","article-title":"Persistent \u03b3H2AX: a promising molecular marker of DNA damage and aging","volume":"766","author":"Siddiqui","year":"2015","journal-title":"Mutat Res Rev Mutat Res"},{"key":"10.1136\/esmoopen-2017-000250_bb0340","first-page":"1876","article-title":"DNA damage is able to induce senescence in tumor cells in vitro and in vivo","volume":"62","author":"te Poele","year":"2002","journal-title":"Cancer Res"},{"key":"10.1136\/esmoopen-2017-000250_bb0345","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.mad.2012.05.007","article-title":"Telomere loss in Philadelphia-negative hematopoiesis after successful treatment of chronic myeloid leukemia: evidence for premature aging of the myeloid compartment","volume":"133","author":"Lobetti-Bodoni","year":"2012","journal-title":"Mech Ageing Dev"},{"key":"10.1136\/esmoopen-2017-000250_bb0350","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/S0140-6736(14)60525-0","article-title":"Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up","volume":"384","author":"Schr\u00f6der","year":"2014","journal-title":"The Lancet"},{"key":"10.1136\/esmoopen-2017-000250_bb0355","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s00277-003-0691-4","article-title":"Telomere length shortening in non-Hodgkin\u2019s lymphoma patients undergoing chemotherapy","volume":"82","author":"Lee","year":"2003","journal-title":"Ann Hematol"},{"key":"10.1136\/esmoopen-2017-000250_bb0360","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ctrv.2012.06.007","article-title":"Novel anticancer therapeutics targeting telomerase","volume":"39","author":"Ruden","year":"2013","journal-title":"Cancer Treat Rev"},{"key":"10.1136\/esmoopen-2017-000250_bb0365","first-page":"5829","article-title":"Drug-induced DNA hypermethylation and drug resistance in human tumors","volume":"49","author":"Nyce","year":"1989","journal-title":"Cancer Res"},{"key":"10.1136\/esmoopen-2017-000250_bb0370","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1089\/rej.2012.1324","article-title":"The role of DNA methylation in aging, rejuvenation, and age-related disease","volume":"15","author":"Johnson","year":"2012","journal-title":"Rejuvenation Res"},{"key":"10.1136\/esmoopen-2017-000250_bb0375","doi-asserted-by":"crossref","first-page":"15805","DOI":"10.1073\/pnas.0707628104","article-title":"MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B","volume":"104","author":"Fabbri","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1136\/esmoopen-2017-000250_bb0380","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s00395-013-0334-4","article-title":"Doxorubicin induces senescence and impairs function of human cardiac progenitor cells","volume":"108","author":"Piegari","year":"2013","journal-title":"Basic Res Cardiol"},{"key":"10.1136\/esmoopen-2017-000250_bb0385","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1097\/01.TP.0000173649.99261.DF","article-title":"Nonmyeloablative conditioning does not prevent telomere shortening after allogeneic stem cell transplantation","volume":"80","author":"Lahav","year":"2005","journal-title":"Transplantation"},{"key":"10.1136\/esmoopen-2017-000250_bb0390","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1182\/blood-2008-09-178871","article-title":"Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells","volume":"114","author":"Calado","year":"2009","journal-title":"Blood"},{"key":"10.1136\/esmoopen-2017-000250_bb0395","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1056\/NEJMoa1515319","article-title":"Danazol treatment for telomere diseases","volume":"374","author":"Townsley","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1136\/esmoopen-2017-000250_bb0400","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1093\/gerona\/glw126","article-title":"Frameworks for proof-of-concept clinical trials of interventions that target fundamental aging processes","volume":"71","author":"Justice","year":"2016","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1136\/esmoopen-2017-000250_bb0405","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000382054","article-title":"Cellular senescence and the biology of aging, disease, and frailty","volume":"83","author":"LeBrasseur","year":"2015","journal-title":"Nestle Nutr Inst Workshop Ser"},{"key":"10.1136\/esmoopen-2017-000250_bb0410","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.exger.2014.10.012","article-title":"Clinical strategies and animal models for developing senolytic agents","volume":"68","author":"Kirkland","year":"2015","journal-title":"Exp Gerontol"},{"key":"10.1136\/esmoopen-2017-000250_bb0415","first-page":"324","article-title":"Cellular senescence and the senescent secretory phenotype in age-related chronic diseases","volume":"17","author":"Zhu","year":"2014","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1136\/esmoopen-2017-000250_bb0420","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0014-4827(61)90192-6","article-title":"The serial cultivation of human diploid cell strains","volume":"25","author":"Hayflick","year":"1961","journal-title":"Exp Cell Res"}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S205970292032384X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S205970292032384X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/esmoopen-2017-000250","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:21:23Z","timestamp":1761855683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S205970292032384X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":83,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017]]}},"alternative-id":["S205970292032384X"],"URL":"https:\/\/doi.org\/10.1136\/esmoopen-2017-000250","relation":{},"ISSN":["2059-7029"],"issn-type":[{"value":"2059-7029","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biology of premature ageing in survivors of cancer","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/esmoopen-2017-000250","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 THE AUTHORS. Published by Elsevier Limited on behalf of European Society for Medical Oncology; Originally published by BMJ.","name":"copyright","label":"Copyright"}],"article-number":"e000250"}}